Envision Eye Center - Educational Optometry Evening 2020
Date: 24/03/2020
Venue: Swissotel 68 Market Street, NSW, 2000
Provider: Envision Eye Centre
Contact: Ursula Kunicki, [E] surgical@corneaclinic.com.au, [P] (02) 9233 7333
Learning Objectives
- Understand the benefits of the world's first online keratoconus registry
- To have an understanding of the optometry module that was developed by our key speaker of the night Prof Stephanie Watson
- Identify the additional fields in keratoconic patients to track vision and contact lens-related outcomes and how to track and share with patients their own outcomes. In addition, improve patient understanding and compliance with therapy.
- Identify patients who would be eligible to participate in the registry
- Understand how to become involved in the Save Sight registry and a demonstration of data collection and statistical analysis
- Understand how to differentiate and diagnose between similar presenting anterior segment cases
- Have a sound understanding of treatment and management of the common presenting anterior segment conditions
- Identify key factors in the initial diagnosis of anterior segment conditions- case studies presented
- Be able to identify and describe various endothelial grafting procedures
- List indications of these procedures and describe their presentations
- Describe expected outcomes for endothelial procedures, as compared to penetrating keratoplasty
- Understanding the use of ozurdex for the treatment of unilateral infective posterior uveitis and its usefulness when doing cataract surgery in uveitis patients
- Understand the way we diagnose, investigate and treat uveitis using multimodal imaging
- Have a sound understanding of how biologic therapy is revolutionizing the fight against noninfective uveitis
- Understanding the importance of a good patient/ doctor relationship in the treatment of diabetic macular oedema with 10 anti-VEGF injections in the first 12 months of treatment as per the drcrnet protocols
- Understand the therapeutic use of Brocolizamab as a possible longer-acting anti-VEGF
Max points awarded: 9.00
Session Information
| Name |
|---|
| Developments in Keratoconus and the Save Sight Registry |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name |
|---|
| Anterior Segment Cases |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |
| Name |
|---|
| DSEK, DMEK, DWEK- What the heck? |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name |
|---|
| Uveitis and Medical Retina case Management Updates |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |